NCT04036578

Efficacy of Biofeedback in Women With Pelvic Floor Dysfunction

Completed NA Last updated 30 July 2019

What this trial tests

NA trial testing A 12-week PFMT bio-assisted surface electromyographic program in Pelvic Floor Dysfunction in 83 participants. Completed in 2 November 2018.

Timeline

1 December 2015

Primary endpoint
24 January 2018

2 November 2018

Quick facts

Lead sponsor	Far Eastern Memorial Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	83
Start date	1 December 2015
Primary completion	24 January 2018
Estimated completion	2 November 2018

Drugs / interventions tested

• A 12-week PFMT bio-assisted surface electromyographic program

Conditions studied

• Pelvic Floor Dysfunction — all drugs for Pelvic Floor Dysfunction →

Sponsor

Far Eastern Memorial Hospital

Who can join

Adults 20 to 85, female only, with Pelvic Floor Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recent studies have found that pelvic floor muscle training can relieve pelvic organ prolapse related symptoms. However, the rate of cure or improvement of symptoms with exercise prescription, different compliance of the patient's behavior have great differences. Biofeedback is an instrument used to record the biological signals ( electrical activity) during a voluntary pelvic floor muscle contraction and provide feedback in auditory or visual form (a louder sound with a stronger squeeze or an increasing number of lights on a visual display as the strength of the squeeze increased). Therefore, this study would explore the efficacy of biofeedback-assisted pelvic floor muscle training in women with pelvic floor dysfunction with or without organ prolapse.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.